First fully integrated spatial multiomic assay from 10x Genomics brings RNA and protein data together in situ – unlocking deeper insights into cell function and disease biology "Scientists can now ...

Initiative led by researchers in Australia and Japan aims to map cancer and immune interactions to advance precision oncology across the region The Garvan Institute of Medical Research brings together ...

On 4, PharosAI announced it would use 10x Genomics’ Xenium spatial platform to convert archived NHS cancer samples into high-resolution, multimodal datasets, backed by £18.9 million in UK government ...

Genomics (NASDAQ:TXG) reported fourth-quarter revenue of $166 million, surpassing the high end of its guidance range, as continued consumables growth and a modest late-quarter “budget flush” helped ...

Initiative will create one of the world's largest multimodal cancer datasets and an integrated suite of AI models and tools to fuel precision medicine PharosAI brings together King's College London, ...

Genomics (TXG) is in focus as investors consider an upcoming earnings report and a new PharosAI collaboration that applies its Xenium spatial platform to large scale, AI driven cancer research ...

First fully integrated spatial multiomic assay from 10x Genomics (TXG) brings RNA and protein data together in situ – unlocking deeper insights into cell function and disease biology PLEASANTON, Calif ...